Publication | Open Access

Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s disease

InflammationChronic Inflammatory DiseasesAutoimmune DiseaseAllergyCrohn ’Mucosal ImmunologyImmunologyGastroenterologyAutoimmunityImmune-mediated Inflammatory DiseasesMedicineInflammatory DiseaseAntibody ResponsesEpisodic Treatment